Treatment of age‐related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4‐year study of treatment outcomes, durability, safety and quality of life (An extension to the <scp>MATE</scp> randomised controlled trial)

Archana Airody*, Heidi A. Baseler, Julie Seymour, Victoria Allgar, Rajarshi Mukherjee, Louise Downey, S Dhar‐Munshi, Sajjad Mahmood, Konstantinos Balaskas, Theo Empeslidis, Rachel L.W. Hanson, Tracey Dorey, Tom Szczerbicki, Sobha Sivaprasad, Richard P. Gale

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Treatment of age‐related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4‐year study of treatment outcomes, durability, safety and quality of life (An extension to the <scp>MATE</scp> randomised controlled trial)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions